THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER H-1B Visa Sponsorship & Salary Data

The median H-1B salary at THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER is $71,466, based on 950 certified filings from FY 2020 to FY 2026. This is 40% lower than the national H-1B median salary of $120,000. Compensation at THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER reflects their market positioning, with entry-level roles starting around $60,000 and senior positions reaching $140,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER range from $52,896 at the 10th percentile to $140,000 at the 90th percentile, showing a $87,104 spread across experience levels and roles. The 25th percentile is $60,000 and the 75th percentile is $85,700.

Yes, THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 1,094 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 950 certified applications and a 0.4% denial rate, THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER filed 36 H-1B applications, with 32 certified and 0 denied. Over 7 years of data, THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's LCA (Labor Condition Application) denial rate is 0.4%, with 4 out of 1,094 applications denied across all years. This translates to a 99.6% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER as a potential H-1B sponsor.

This is an excellent approval rate, indicating THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 950 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER:

The most frequently sponsored role is Principal Research Associate with 194 filings at a median salary of $61,572. This is followed by Research Scientist (163 filings) and Assistant Professor.

THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER H-1B locations:

The largest H-1B hub for THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER is Houston, TX with 935 filings at a median salary of $71,616. The highest-paying location is Bastrop, TX at $169,000 median. Salaries range from $44,034 to $169,000 across office locations.

THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's median H-1B salary has increased by +38% from FY 2020 ($56,880) to FY 2026 ($78,500). Tracking salary trends over time reveals how THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER.

Year-by-year breakdown:

• FY 2022: $65,000 (149 certified)
• FY 2023: $68,421 (164 certified)
• FY 2024: $74,150 (161 certified)
• FY 2025: $79,500 (195 certified)
• FY 2026: $78,500 (32 certified)

This 38% growth reflects strong compensation adjustments at THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER, keeping pace with market demands for H-1B talent.

THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER primarily files H-1B applications at Wage Level I, accounting for 65% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

A significant portion of THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's H-1B filings are at entry-level (Level I) wages. These positions may face more competition in the H-1B lottery.

THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's median H-1B salary of $71,466 is 40% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's offerings with similar companies in your field for a more accurate assessment.

THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER files 65% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 950 certified filings, THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER invests significantly in H-1B sponsorship. The company's 0.4% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.